Redox, a Madison, WI-based integration platform for digital healthcare applications, closed a $9m Series B financing.
The round was led by RRE Ventures with participation from existing investors .406 Ventures, HealthX Ventures, and Flybridge Capital Partners.
The company intends to use the funds to accelerate its product roadmap.
Launched in 2014 by Luke Bonney, CEO, and Niko Skievaski, President, Redox simplifies healthcare integration and facilitates data exchange between organizations. Its interoperable network allows digital health applications, healthcare organizations, HIEs, lab systems, payors, pharmaceutical companies, registries, and technology providers to and securely share data.
FinSMEs
25/01/2017